nodes	percent_of_prediction	percent_of_DWPC	metapath
Clemastine—CYP2D6—Captopril—systemic scleroderma	0.0675	0.526	CbGbCtD
Clemastine—CYP3A4—Mycophenolate mofetil—systemic scleroderma	0.0338	0.263	CbGbCtD
Clemastine—CYP3A4—Prednisone—systemic scleroderma	0.027	0.211	CbGbCtD
Clemastine—Diplopia—Lisinopril—systemic scleroderma	0.00541	0.0062	CcSEcCtD
Clemastine—Palpitations—Pentoxifylline—systemic scleroderma	0.00536	0.00615	CcSEcCtD
Clemastine—Sweating increased—Leflunomide—systemic scleroderma	0.0053	0.00608	CcSEcCtD
Clemastine—Convulsion—Pentoxifylline—systemic scleroderma	0.00526	0.00603	CcSEcCtD
Clemastine—Haemolytic anaemia—Mycophenolate mofetil—systemic scleroderma	0.00525	0.00602	CcSEcCtD
Clemastine—Irritability—Lisinopril—systemic scleroderma	0.00516	0.00592	CcSEcCtD
Clemastine—Pollakiuria—Leflunomide—systemic scleroderma	0.00502	0.00576	CcSEcCtD
Clemastine—Confusional state—Pentoxifylline—systemic scleroderma	0.00499	0.00573	CcSEcCtD
Clemastine—Anaphylactic shock—Pentoxifylline—systemic scleroderma	0.00495	0.00568	CcSEcCtD
Clemastine—Thrombocytopenia—Pentoxifylline—systemic scleroderma	0.00485	0.00556	CcSEcCtD
Clemastine—Tachycardia—Pentoxifylline—systemic scleroderma	0.00483	0.00554	CcSEcCtD
Clemastine—Pollakiuria—Mycophenolic acid—systemic scleroderma	0.00479	0.0055	CcSEcCtD
Clemastine—Agranulocytosis—Azathioprine—systemic scleroderma	0.00479	0.0055	CcSEcCtD
Clemastine—Hyperhidrosis—Pentoxifylline—systemic scleroderma	0.00479	0.00549	CcSEcCtD
Clemastine—Neuropathy peripheral—Leflunomide—systemic scleroderma	0.00475	0.00545	CcSEcCtD
Clemastine—Diplopia—Mycophenolate mofetil—systemic scleroderma	0.00474	0.00543	CcSEcCtD
Clemastine—Anorexia—Pentoxifylline—systemic scleroderma	0.00472	0.00541	CcSEcCtD
Clemastine—Hypotension—Pentoxifylline—systemic scleroderma	0.00463	0.00531	CcSEcCtD
Clemastine—Sweating increased—Lisinopril—systemic scleroderma	0.00455	0.00522	CcSEcCtD
Clemastine—Neuropathy peripheral—Mycophenolic acid—systemic scleroderma	0.00453	0.0052	CcSEcCtD
Clemastine—Agranulocytosis—Leflunomide—systemic scleroderma	0.00453	0.00519	CcSEcCtD
Clemastine—Tension—Captopril—systemic scleroderma	0.00451	0.00518	CcSEcCtD
Clemastine—Urinary retention—Mycophenolate mofetil—systemic scleroderma	0.0045	0.00517	CcSEcCtD
Clemastine—Insomnia—Pentoxifylline—systemic scleroderma	0.00448	0.00514	CcSEcCtD
Clemastine—Nervousness—Captopril—systemic scleroderma	0.00447	0.00512	CcSEcCtD
Clemastine—Somnolence—Pentoxifylline—systemic scleroderma	0.0044	0.00505	CcSEcCtD
Clemastine—Dyspepsia—Pentoxifylline—systemic scleroderma	0.00436	0.005	CcSEcCtD
Clemastine—Vision blurred—Captopril—systemic scleroderma	0.00433	0.00497	CcSEcCtD
Clemastine—Agranulocytosis—Mycophenolic acid—systemic scleroderma	0.00432	0.00495	CcSEcCtD
Clemastine—Decreased appetite—Pentoxifylline—systemic scleroderma	0.0043	0.00494	CcSEcCtD
Clemastine—Anaphylactic shock—Mometasone—systemic scleroderma	0.00427	0.0049	CcSEcCtD
Clemastine—Photosensitivity reaction—Lisinopril—systemic scleroderma	0.00427	0.00489	CcSEcCtD
Clemastine—Constipation—Pentoxifylline—systemic scleroderma	0.00423	0.00486	CcSEcCtD
Clemastine—Chills—Azathioprine—systemic scleroderma	0.00414	0.00474	CcSEcCtD
Clemastine—Neuropathy peripheral—Lisinopril—systemic scleroderma	0.00408	0.00469	CcSEcCtD
Clemastine—Feeling abnormal—Pentoxifylline—systemic scleroderma	0.00408	0.00468	CcSEcCtD
Clemastine—Anorexia—Mometasone—systemic scleroderma	0.00407	0.00467	CcSEcCtD
Clemastine—Palpitations—Captopril—systemic scleroderma	0.00406	0.00466	CcSEcCtD
Clemastine—Chills—Leflunomide—systemic scleroderma	0.00391	0.00448	CcSEcCtD
Clemastine—Agranulocytosis—Lisinopril—systemic scleroderma	0.00389	0.00446	CcSEcCtD
Clemastine—Tinnitus—Mycophenolic acid—systemic scleroderma	0.00387	0.00444	CcSEcCtD
Clemastine—Paraesthesia—Mometasone—systemic scleroderma	0.00384	0.0044	CcSEcCtD
Clemastine—Euphoric mood—Prednisone—systemic scleroderma	0.0038	0.00436	CcSEcCtD
Clemastine—Confusional state—Captopril—systemic scleroderma	0.00378	0.00434	CcSEcCtD
Clemastine—Pollakiuria—Mycophenolate mofetil—systemic scleroderma	0.00378	0.00434	CcSEcCtD
Clemastine—Dyspepsia—Mometasone—systemic scleroderma	0.00376	0.00431	CcSEcCtD
Clemastine—Anaphylactic shock—Captopril—systemic scleroderma	0.00375	0.0043	CcSEcCtD
Clemastine—Chills—Mycophenolic acid—systemic scleroderma	0.00373	0.00427	CcSEcCtD
Clemastine—Decreased appetite—Mometasone—systemic scleroderma	0.00371	0.00426	CcSEcCtD
Clemastine—Fatigue—Mometasone—systemic scleroderma	0.00368	0.00423	CcSEcCtD
Clemastine—Thrombocytopenia—Captopril—systemic scleroderma	0.00367	0.00421	CcSEcCtD
Clemastine—Tachycardia—Captopril—systemic scleroderma	0.00366	0.0042	CcSEcCtD
Clemastine—Neuropathy peripheral—Mycophenolate mofetil—systemic scleroderma	0.00358	0.00411	CcSEcCtD
Clemastine—Anorexia—Captopril—systemic scleroderma	0.00358	0.0041	CcSEcCtD
Clemastine—Vision blurred—Leflunomide—systemic scleroderma	0.00357	0.0041	CcSEcCtD
Clemastine—Asthenia—Pentoxifylline—systemic scleroderma	0.00355	0.00408	CcSEcCtD
Clemastine—Tension—Mycophenolic acid—systemic scleroderma	0.00355	0.00407	CcSEcCtD
Clemastine—Nervousness—Mycophenolic acid—systemic scleroderma	0.00351	0.00403	CcSEcCtD
Clemastine—Hypotension—Captopril—systemic scleroderma	0.00351	0.00402	CcSEcCtD
Clemastine—Tinnitus—Lisinopril—systemic scleroderma	0.00349	0.004	CcSEcCtD
Clemastine—Vision blurred—Mycophenolic acid—systemic scleroderma	0.00341	0.00391	CcSEcCtD
Clemastine—Agranulocytosis—Mycophenolate mofetil—systemic scleroderma	0.00341	0.00391	CcSEcCtD
Clemastine—Vertigo—Leflunomide—systemic scleroderma	0.0034	0.00391	CcSEcCtD
Clemastine—Insomnia—Captopril—systemic scleroderma	0.00339	0.00389	CcSEcCtD
Clemastine—Diarrhoea—Pentoxifylline—systemic scleroderma	0.00339	0.00389	CcSEcCtD
Clemastine—Tremor—Mycophenolic acid—systemic scleroderma	0.00339	0.00389	CcSEcCtD
Clemastine—Paraesthesia—Captopril—systemic scleroderma	0.00337	0.00387	CcSEcCtD
Clemastine—Chills—Lisinopril—systemic scleroderma	0.00336	0.00385	CcSEcCtD
Clemastine—Palpitations—Leflunomide—systemic scleroderma	0.00335	0.00384	CcSEcCtD
Clemastine—Somnolence—Captopril—systemic scleroderma	0.00334	0.00383	CcSEcCtD
Clemastine—Agitation—Mycophenolic acid—systemic scleroderma	0.00332	0.00381	CcSEcCtD
Clemastine—Dyspepsia—Captopril—systemic scleroderma	0.0033	0.00379	CcSEcCtD
Clemastine—Dizziness—Pentoxifylline—systemic scleroderma	0.00327	0.00376	CcSEcCtD
Clemastine—Decreased appetite—Captopril—systemic scleroderma	0.00326	0.00374	CcSEcCtD
Clemastine—Vertigo—Mycophenolic acid—systemic scleroderma	0.00325	0.00373	CcSEcCtD
Clemastine—Fatigue—Captopril—systemic scleroderma	0.00324	0.00371	CcSEcCtD
Clemastine—Constipation—Captopril—systemic scleroderma	0.00321	0.00368	CcSEcCtD
Clemastine—Thrombocytopenia—Azathioprine—systemic scleroderma	0.00321	0.00368	CcSEcCtD
Clemastine—Tension—Lisinopril—systemic scleroderma	0.0032	0.00367	CcSEcCtD
Clemastine—Palpitations—Mycophenolic acid—systemic scleroderma	0.00319	0.00366	CcSEcCtD
Clemastine—Nervousness—Lisinopril—systemic scleroderma	0.00316	0.00363	CcSEcCtD
Clemastine—Vomiting—Pentoxifylline—systemic scleroderma	0.00315	0.00361	CcSEcCtD
Clemastine—Convulsion—Mycophenolic acid—systemic scleroderma	0.00313	0.00359	CcSEcCtD
Clemastine—Headache—Pentoxifylline—systemic scleroderma	0.0031	0.00356	CcSEcCtD
Clemastine—Anaphylactic shock—Leflunomide—systemic scleroderma	0.00309	0.00355	CcSEcCtD
Clemastine—Feeling abnormal—Captopril—systemic scleroderma	0.00309	0.00355	CcSEcCtD
Clemastine—Vision blurred—Lisinopril—systemic scleroderma	0.00307	0.00352	CcSEcCtD
Clemastine—Asthenia—Mometasone—systemic scleroderma	0.00307	0.00352	CcSEcCtD
Clemastine—Irritability—Prednisone—systemic scleroderma	0.00307	0.00352	CcSEcCtD
Clemastine—Hypotension—Azathioprine—systemic scleroderma	0.00306	0.00351	CcSEcCtD
Clemastine—Photosensitivity—Methotrexate—systemic scleroderma	0.00306	0.00351	CcSEcCtD
Clemastine—Tinnitus—Mycophenolate mofetil—systemic scleroderma	0.00306	0.00351	CcSEcCtD
Clemastine—Tremor—Lisinopril—systemic scleroderma	0.00305	0.0035	CcSEcCtD
Clemastine—Thrombocytopenia—Leflunomide—systemic scleroderma	0.00303	0.00347	CcSEcCtD
Clemastine—Tachycardia—Leflunomide—systemic scleroderma	0.00302	0.00346	CcSEcCtD
Clemastine—Hyperhidrosis—Leflunomide—systemic scleroderma	0.00299	0.00343	CcSEcCtD
Clemastine—Confusional state—Mycophenolic acid—systemic scleroderma	0.00297	0.00341	CcSEcCtD
Clemastine—Anorexia—Leflunomide—systemic scleroderma	0.00295	0.00338	CcSEcCtD
Clemastine—Nausea—Pentoxifylline—systemic scleroderma	0.00294	0.00337	CcSEcCtD
Clemastine—Chills—Mycophenolate mofetil—systemic scleroderma	0.00294	0.00337	CcSEcCtD
Clemastine—Vertigo—Lisinopril—systemic scleroderma	0.00293	0.00336	CcSEcCtD
Clemastine—Diarrhoea—Mometasone—systemic scleroderma	0.00292	0.00335	CcSEcCtD
Clemastine—Hypotension—Leflunomide—systemic scleroderma	0.00289	0.00332	CcSEcCtD
Clemastine—Thrombocytopenia—Mycophenolic acid—systemic scleroderma	0.00289	0.00331	CcSEcCtD
Clemastine—Tachycardia—Mycophenolic acid—systemic scleroderma	0.00288	0.0033	CcSEcCtD
Clemastine—Palpitations—Lisinopril—systemic scleroderma	0.00288	0.0033	CcSEcCtD
Clemastine—Hyperhidrosis—Mycophenolic acid—systemic scleroderma	0.00285	0.00327	CcSEcCtD
Clemastine—Anorexia—Mycophenolic acid—systemic scleroderma	0.00281	0.00323	CcSEcCtD
Clemastine—Tension—Mycophenolate mofetil—systemic scleroderma	0.0028	0.00321	CcSEcCtD
Clemastine—Insomnia—Leflunomide—systemic scleroderma	0.0028	0.00321	CcSEcCtD
Clemastine—Paraesthesia—Leflunomide—systemic scleroderma	0.00278	0.00319	CcSEcCtD
Clemastine—Nervousness—Mycophenolate mofetil—systemic scleroderma	0.00277	0.00318	CcSEcCtD
Clemastine—Hypotension—Mycophenolic acid—systemic scleroderma	0.00276	0.00316	CcSEcCtD
Clemastine—Dyspepsia—Leflunomide—systemic scleroderma	0.00272	0.00312	CcSEcCtD
Clemastine—Vomiting—Mometasone—systemic scleroderma	0.00272	0.00312	CcSEcCtD
Clemastine—Sweating increased—Prednisone—systemic scleroderma	0.0027	0.0031	CcSEcCtD
Clemastine—Feeling abnormal—Azathioprine—systemic scleroderma	0.0027	0.0031	CcSEcCtD
Clemastine—Asthenia—Captopril—systemic scleroderma	0.00269	0.00309	CcSEcCtD
Clemastine—Decreased appetite—Leflunomide—systemic scleroderma	0.00269	0.00308	CcSEcCtD
Clemastine—Confusional state—Lisinopril—systemic scleroderma	0.00268	0.00307	CcSEcCtD
Clemastine—Headache—Mometasone—systemic scleroderma	0.00268	0.00307	CcSEcCtD
Clemastine—Tremor—Mycophenolate mofetil—systemic scleroderma	0.00267	0.00307	CcSEcCtD
Clemastine—Insomnia—Mycophenolic acid—systemic scleroderma	0.00267	0.00306	CcSEcCtD
Clemastine—Fatigue—Leflunomide—systemic scleroderma	0.00267	0.00306	CcSEcCtD
Clemastine—Anaphylactic shock—Lisinopril—systemic scleroderma	0.00266	0.00305	CcSEcCtD
Clemastine—Paraesthesia—Mycophenolic acid—systemic scleroderma	0.00265	0.00304	CcSEcCtD
Clemastine—Constipation—Leflunomide—systemic scleroderma	0.00264	0.00303	CcSEcCtD
Clemastine—Somnolence—Mycophenolic acid—systemic scleroderma	0.00262	0.00301	CcSEcCtD
Clemastine—Agitation—Mycophenolate mofetil—systemic scleroderma	0.00262	0.00301	CcSEcCtD
Clemastine—Thrombocytopenia—Lisinopril—systemic scleroderma	0.0026	0.00298	CcSEcCtD
Clemastine—Dyspepsia—Mycophenolic acid—systemic scleroderma	0.0026	0.00298	CcSEcCtD
Clemastine—Tachycardia—Lisinopril—systemic scleroderma	0.00259	0.00298	CcSEcCtD
Clemastine—Hyperhidrosis—Lisinopril—systemic scleroderma	0.00257	0.00295	CcSEcCtD
Clemastine—Diarrhoea—Captopril—systemic scleroderma	0.00257	0.00295	CcSEcCtD
Clemastine—Decreased appetite—Mycophenolic acid—systemic scleroderma	0.00256	0.00294	CcSEcCtD
Clemastine—Vertigo—Mycophenolate mofetil—systemic scleroderma	0.00256	0.00294	CcSEcCtD
Clemastine—Irritability—Methotrexate—systemic scleroderma	0.00256	0.00294	CcSEcCtD
Clemastine—Feeling abnormal—Leflunomide—systemic scleroderma	0.00255	0.00292	CcSEcCtD
Clemastine—Fatigue—Mycophenolic acid—systemic scleroderma	0.00254	0.00292	CcSEcCtD
Clemastine—Nausea—Mometasone—systemic scleroderma	0.00254	0.00291	CcSEcCtD
Clemastine—Anorexia—Lisinopril—systemic scleroderma	0.00253	0.00291	CcSEcCtD
Clemastine—Constipation—Mycophenolic acid—systemic scleroderma	0.00252	0.00289	CcSEcCtD
Clemastine—Palpitations—Mycophenolate mofetil—systemic scleroderma	0.00252	0.00289	CcSEcCtD
Clemastine—Hypotension—Lisinopril—systemic scleroderma	0.00248	0.00285	CcSEcCtD
Clemastine—Dizziness—Captopril—systemic scleroderma	0.00248	0.00285	CcSEcCtD
Clemastine—Convulsion—Mycophenolate mofetil—systemic scleroderma	0.00247	0.00284	CcSEcCtD
Clemastine—Feeling abnormal—Mycophenolic acid—systemic scleroderma	0.00243	0.00279	CcSEcCtD
Clemastine—Neuropathy peripheral—Prednisone—systemic scleroderma	0.00243	0.00278	CcSEcCtD
Clemastine—Insomnia—Lisinopril—systemic scleroderma	0.0024	0.00276	CcSEcCtD
Clemastine—Paraesthesia—Lisinopril—systemic scleroderma	0.00239	0.00274	CcSEcCtD
Clemastine—Vomiting—Captopril—systemic scleroderma	0.00239	0.00274	CcSEcCtD
Clemastine—Somnolence—Lisinopril—systemic scleroderma	0.00236	0.00271	CcSEcCtD
Clemastine—Headache—Captopril—systemic scleroderma	0.00235	0.0027	CcSEcCtD
Clemastine—Confusional state—Mycophenolate mofetil—systemic scleroderma	0.00235	0.00269	CcSEcCtD
Clemastine—Dyspepsia—Lisinopril—systemic scleroderma	0.00234	0.00268	CcSEcCtD
Clemastine—Anaphylactic shock—Mycophenolate mofetil—systemic scleroderma	0.00233	0.00267	CcSEcCtD
Clemastine—Decreased appetite—Lisinopril—systemic scleroderma	0.00231	0.00265	CcSEcCtD
Clemastine—Fatigue—Lisinopril—systemic scleroderma	0.00229	0.00263	CcSEcCtD
Clemastine—Thrombocytopenia—Mycophenolate mofetil—systemic scleroderma	0.00228	0.00262	CcSEcCtD
Clemastine—Constipation—Lisinopril—systemic scleroderma	0.00227	0.00261	CcSEcCtD
Clemastine—Tachycardia—Mycophenolate mofetil—systemic scleroderma	0.00227	0.00261	CcSEcCtD
Clemastine—Hyperhidrosis—Mycophenolate mofetil—systemic scleroderma	0.00225	0.00258	CcSEcCtD
Clemastine—Diarrhoea—Azathioprine—systemic scleroderma	0.00224	0.00257	CcSEcCtD
Clemastine—Nausea—Captopril—systemic scleroderma	0.00223	0.00256	CcSEcCtD
Clemastine—Anorexia—Mycophenolate mofetil—systemic scleroderma	0.00222	0.00255	CcSEcCtD
Clemastine—Asthenia—Leflunomide—systemic scleroderma	0.00222	0.00255	CcSEcCtD
Clemastine—Feeling abnormal—Lisinopril—systemic scleroderma	0.00219	0.00251	CcSEcCtD
Clemastine—Hypotension—Mycophenolate mofetil—systemic scleroderma	0.00218	0.0025	CcSEcCtD
Clemastine—Dizziness—Azathioprine—systemic scleroderma	0.00217	0.00248	CcSEcCtD
Clemastine—Photosensitivity reaction—Methotrexate—systemic scleroderma	0.00212	0.00243	CcSEcCtD
Clemastine—Asthenia—Mycophenolic acid—systemic scleroderma	0.00212	0.00243	CcSEcCtD
Clemastine—Diarrhoea—Leflunomide—systemic scleroderma	0.00212	0.00243	CcSEcCtD
Clemastine—Insomnia—Mycophenolate mofetil—systemic scleroderma	0.00211	0.00242	CcSEcCtD
Clemastine—Paraesthesia—Mycophenolate mofetil—systemic scleroderma	0.00209	0.0024	CcSEcCtD
Clemastine—Vomiting—Azathioprine—systemic scleroderma	0.00208	0.00239	CcSEcCtD
Clemastine—Somnolence—Mycophenolate mofetil—systemic scleroderma	0.00207	0.00237	CcSEcCtD
Clemastine—Drowsiness—Methotrexate—systemic scleroderma	0.00207	0.00237	CcSEcCtD
Clemastine—Headache—Azathioprine—systemic scleroderma	0.00205	0.00235	CcSEcCtD
Clemastine—Dyspepsia—Mycophenolate mofetil—systemic scleroderma	0.00205	0.00235	CcSEcCtD
Clemastine—Dizziness—Leflunomide—systemic scleroderma	0.00205	0.00235	CcSEcCtD
Clemastine—Decreased appetite—Mycophenolate mofetil—systemic scleroderma	0.00202	0.00232	CcSEcCtD
Clemastine—Diarrhoea—Mycophenolic acid—systemic scleroderma	0.00202	0.00232	CcSEcCtD
Clemastine—Constipation—Mycophenolate mofetil—systemic scleroderma	0.00199	0.00228	CcSEcCtD
Clemastine—Vomiting—Leflunomide—systemic scleroderma	0.00197	0.00226	CcSEcCtD
Clemastine—Dizziness—Mycophenolic acid—systemic scleroderma	0.00195	0.00224	CcSEcCtD
Clemastine—Nausea—Azathioprine—systemic scleroderma	0.00195	0.00223	CcSEcCtD
Clemastine—Headache—Leflunomide—systemic scleroderma	0.00194	0.00222	CcSEcCtD
Clemastine—Agranulocytosis—Methotrexate—systemic scleroderma	0.00193	0.00221	CcSEcCtD
Clemastine—Feeling abnormal—Mycophenolate mofetil—systemic scleroderma	0.00192	0.0022	CcSEcCtD
Clemastine—Asthenia—Lisinopril—systemic scleroderma	0.00191	0.00219	CcSEcCtD
Clemastine—Vomiting—Mycophenolic acid—systemic scleroderma	0.00188	0.00215	CcSEcCtD
Clemastine—Headache—Mycophenolic acid—systemic scleroderma	0.00185	0.00212	CcSEcCtD
Clemastine—Nausea—Leflunomide—systemic scleroderma	0.00184	0.00211	CcSEcCtD
Clemastine—Vision blurred—Prednisone—systemic scleroderma	0.00182	0.00209	CcSEcCtD
Clemastine—Diarrhoea—Lisinopril—systemic scleroderma	0.00182	0.00209	CcSEcCtD
Clemastine—Agitation—Prednisone—systemic scleroderma	0.00178	0.00204	CcSEcCtD
Clemastine—Dizziness—Lisinopril—systemic scleroderma	0.00176	0.00202	CcSEcCtD
Clemastine—Nausea—Mycophenolic acid—systemic scleroderma	0.00175	0.00201	CcSEcCtD
Clemastine—Vertigo—Prednisone—systemic scleroderma	0.00174	0.00199	CcSEcCtD
Clemastine—Tinnitus—Methotrexate—systemic scleroderma	0.00173	0.00199	CcSEcCtD
Clemastine—Vomiting—Lisinopril—systemic scleroderma	0.00169	0.00194	CcSEcCtD
Clemastine—Convulsion—Prednisone—systemic scleroderma	0.00168	0.00192	CcSEcCtD
Clemastine—Asthenia—Mycophenolate mofetil—systemic scleroderma	0.00167	0.00192	CcSEcCtD
Clemastine—Chills—Methotrexate—systemic scleroderma	0.00167	0.00191	CcSEcCtD
Clemastine—Headache—Lisinopril—systemic scleroderma	0.00166	0.00191	CcSEcCtD
Clemastine—Diarrhoea—Mycophenolate mofetil—systemic scleroderma	0.00159	0.00183	CcSEcCtD
Clemastine—Nausea—Lisinopril—systemic scleroderma	0.00158	0.00181	CcSEcCtD
Clemastine—Anaphylactic shock—Prednisone—systemic scleroderma	0.00158	0.00181	CcSEcCtD
Clemastine—Tachycardia—Prednisone—systemic scleroderma	0.00154	0.00177	CcSEcCtD
Clemastine—Dizziness—Mycophenolate mofetil—systemic scleroderma	0.00154	0.00177	CcSEcCtD
Clemastine—Hyperhidrosis—Prednisone—systemic scleroderma	0.00153	0.00175	CcSEcCtD
Clemastine—Vision blurred—Methotrexate—systemic scleroderma	0.00152	0.00175	CcSEcCtD
Clemastine—Anorexia—Prednisone—systemic scleroderma	0.0015	0.00173	CcSEcCtD
Clemastine—Vomiting—Mycophenolate mofetil—systemic scleroderma	0.00148	0.0017	CcSEcCtD
Clemastine—Headache—Mycophenolate mofetil—systemic scleroderma	0.00146	0.00167	CcSEcCtD
Clemastine—Vertigo—Methotrexate—systemic scleroderma	0.00145	0.00167	CcSEcCtD
Clemastine—Insomnia—Prednisone—systemic scleroderma	0.00143	0.00164	CcSEcCtD
Clemastine—Paraesthesia—Prednisone—systemic scleroderma	0.00142	0.00163	CcSEcCtD
Clemastine—Convulsion—Methotrexate—systemic scleroderma	0.0014	0.00161	CcSEcCtD
Clemastine—Dyspepsia—Prednisone—systemic scleroderma	0.00139	0.00159	CcSEcCtD
Clemastine—Nausea—Mycophenolate mofetil—systemic scleroderma	0.00138	0.00159	CcSEcCtD
Clemastine—Decreased appetite—Prednisone—systemic scleroderma	0.00137	0.00157	CcSEcCtD
Clemastine—Fatigue—Prednisone—systemic scleroderma	0.00136	0.00156	CcSEcCtD
Clemastine—Constipation—Prednisone—systemic scleroderma	0.00135	0.00155	CcSEcCtD
Clemastine—Confusional state—Methotrexate—systemic scleroderma	0.00133	0.00153	CcSEcCtD
Clemastine—Anaphylactic shock—Methotrexate—systemic scleroderma	0.00132	0.00151	CcSEcCtD
Clemastine—Feeling abnormal—Prednisone—systemic scleroderma	0.0013	0.00149	CcSEcCtD
Clemastine—Thrombocytopenia—Methotrexate—systemic scleroderma	0.00129	0.00148	CcSEcCtD
Clemastine—Hyperhidrosis—Methotrexate—systemic scleroderma	0.00128	0.00146	CcSEcCtD
Clemastine—Anorexia—Methotrexate—systemic scleroderma	0.00126	0.00144	CcSEcCtD
Clemastine—Hypotension—Methotrexate—systemic scleroderma	0.00123	0.00141	CcSEcCtD
Clemastine—Insomnia—Methotrexate—systemic scleroderma	0.00119	0.00137	CcSEcCtD
Clemastine—Paraesthesia—Methotrexate—systemic scleroderma	0.00118	0.00136	CcSEcCtD
Clemastine—Somnolence—Methotrexate—systemic scleroderma	0.00117	0.00135	CcSEcCtD
Clemastine—Dyspepsia—Methotrexate—systemic scleroderma	0.00116	0.00133	CcSEcCtD
Clemastine—Decreased appetite—Methotrexate—systemic scleroderma	0.00115	0.00132	CcSEcCtD
Clemastine—Fatigue—Methotrexate—systemic scleroderma	0.00114	0.0013	CcSEcCtD
Clemastine—Asthenia—Prednisone—systemic scleroderma	0.00113	0.0013	CcSEcCtD
Clemastine—Feeling abnormal—Methotrexate—systemic scleroderma	0.00109	0.00125	CcSEcCtD
Clemastine—Diarrhoea—Prednisone—systemic scleroderma	0.00108	0.00124	CcSEcCtD
Clemastine—Dizziness—Prednisone—systemic scleroderma	0.00104	0.0012	CcSEcCtD
Clemastine—Vomiting—Prednisone—systemic scleroderma	0.001	0.00115	CcSEcCtD
Clemastine—Headache—Prednisone—systemic scleroderma	0.000989	0.00113	CcSEcCtD
Clemastine—Asthenia—Methotrexate—systemic scleroderma	0.000946	0.00109	CcSEcCtD
Clemastine—Nausea—Prednisone—systemic scleroderma	0.000937	0.00108	CcSEcCtD
Clemastine—Diarrhoea—Methotrexate—systemic scleroderma	0.000902	0.00104	CcSEcCtD
Clemastine—Dizziness—Methotrexate—systemic scleroderma	0.000872	0.001	CcSEcCtD
Clemastine—Vomiting—Methotrexate—systemic scleroderma	0.000839	0.000962	CcSEcCtD
Clemastine—Headache—Methotrexate—systemic scleroderma	0.000826	0.000948	CcSEcCtD
Clemastine—Nausea—Methotrexate—systemic scleroderma	0.000783	0.000899	CcSEcCtD
